Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024

BUY
$0.36 - $24.24 $5,119 - $344,717
14,221 New
14,221 $5,000
Q4 2022

Feb 13, 2023

BUY
$0.36 - $24.24 $5,119 - $344,717
14,221 New
14,221 $5,000
Q1 2022

May 16, 2022

SELL
$0.74 - $1.22 $18,225 - $30,047
-24,629 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.11 - $1.86 $5,112 - $8,567
-4,606 Reduced 15.76%
24,629 $28,000
Q3 2021

Nov 10, 2021

BUY
$1.78 - $3.41 $52,038 - $99,691
29,235 New
29,235 $52,000

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ASLAN Pharmaceuticals Ltd


  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.